Novo Nordisk ADR (NVO) down -23.97% since start of the year

Novo Nordisk ADR (NYSE: NVO) is -23.97% lower on its value in year-to-date trading and has touched a low of $57.00 and a high of $148.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVO stock was last observed hovering at around $67.74 in the last trading session, with the day’s loss setting it -2.34%.

Currently trading at $65.40, the stock is 1.75% and -6.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 10.26 million and changing -3.45% at the moment leaves the stock -34.15% off its SMA200. NVO registered -49.17% loss for a year compared to 6-month loss of -39.24%.

The stock witnessed a 1.04% gain in the last 1 month and extending the period to 3 months gives it a -21.90%, and is -1.34% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.58% over the week and 2.96% over the month.

Novo Nordisk ADR (NVO) has around 76302 employees, a market worth around $220.14B and $43.59B in sales. Current P/E ratio is 19.40 and Fwd P/E is 13.78. Profit margin for the company is 34.52%. Distance from 52-week low is 14.74% and -55.86% from its 52-week high. The company has generated returns on investments over the last 12 months (44.25%).

The EPS is expected to grow by 25.99% this year.

Novo Nordisk ADR (NVO) Top Institutional Holders

The shares outstanding are 3.37B, and float is at 3.37B with Short Float at 0.75%.

The top institutional shareholder in the company is JENNISON ASSOCIATES LLC with over 21.22 million shares valued at $3.03 billion. The investor’s holdings represent 0.476% of the NVO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 19.49 million shares valued at $2.78 billion to account for 0.4373 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 14.61 million shares representing 0.3278% and valued at over $2.09 billion, while BANK OF AMERICA CORP /DE/ holds 0.3183 of the shares totaling 14.19 million with a market value of $2.03 billion.